Skip to content

Clinical trials

Psychotic Disorders trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Country / region: Czechia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20061
20111
20171
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Solvay Pharmaceuticals2
ACADIA Pharmaceuticals Inc.1
European Group for Research In Schizophrenia1
Intra-Cellular Therapies, Inc.1
Janssen-Cilag International NV1
MapLight Therapeutics1
Philipp Homan1
Rene Kahn1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders11
Schizophrenia6
Alzheimer Disease3
Dementia2
Hallucinations2
Brain Diseases1
Central Nervous System Diseases1
Cognitive Dysfunction1
Corticobasal Degeneration1
Dementia, Vascular1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.